These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19475683)

  • 1. Activation of the cholehepatic shunt as a potential therapy for primary sclerosing cholangitis.
    Glaser SS; Alpini G
    Hepatology; 2009 Jun; 49(6):1795-7. PubMed ID: 19475683
    [No Abstract]   [Full Text] [Related]  

  • 2. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
    Fickert P; Wagner M; Marschall HU; Fuchsbichler A; Zollner G; Tsybrovskyy O; Zatloukal K; Liu J; Waalkes MP; Cover C; Denk H; Hofmann AF; Jaeschke H; Trauner M
    Gastroenterology; 2006 Feb; 130(2):465-81. PubMed ID: 16472600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
    Silveira MG; Lindor KD
    J Hepatol; 2008 May; 48(5):692-4. PubMed ID: 18336948
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?
    Chapman RW
    Hepatology; 2009 Sep; 50(3):671-3. PubMed ID: 19714717
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of primary sclerosing cholangitis with ursodeoxycholic acid].
    Stiehl A; Raedsch R
    Z Gastroenterol Verh; 1989 Jul; 24():136. PubMed ID: 2474928
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis and medical therapy of primary sclerosing cholangitis.
    van Milligen de Wit AW
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):940. PubMed ID: 10514135
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward better treatment of primary sclerosing cholangitis.
    Kaplan MM
    N Engl J Med; 1997 Mar; 336(10):719-21. PubMed ID: 9041105
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of primary sclerosing cholangitis].
    Stiehl A; Benz C; Sauer P
    Praxis (Bern 1994); 2000 May; 89(22):975-7. PubMed ID: 10893998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy.
    Fong DG; Lindor KD
    Am J Gastroenterol; 2000 Aug; 95(8):1861-2. PubMed ID: 10950026
    [No Abstract]   [Full Text] [Related]  

  • 10. A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
    Suskind DL; Finn L; Wahbeh G; Christie D; Horslen S
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):542-4. PubMed ID: 17033534
    [No Abstract]   [Full Text] [Related]  

  • 11. Bile acids for PSC: promise for the future or placebo for the present?
    Yotseff P
    Am J Gastroenterol; 1993 Apr; 88(4):608-9. PubMed ID: 8470648
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
    MMW Fortschr Med; 2006 Jun; 148(24):42-3. PubMed ID: 16850808
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
    Charatcharoenwitthaya P; Lindor KD
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):32-6. PubMed ID: 17234554
    [No Abstract]   [Full Text] [Related]  

  • 14. The medical management of primary sclerosing cholangitis.
    Cullen SN; Chapman RW
    Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical approaches to primary sclerosing cholangitis.
    Kaplan MM
    Semin Liver Dis; 1991 Feb; 11(1):56-63. PubMed ID: 2047891
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary sclerosing cholangitis. Ursodeoxycholic acid is without clinical effect].
    Eisenburg J
    Fortschr Med; 1997 Jun; 115(18):7-8. PubMed ID: 9324488
    [No Abstract]   [Full Text] [Related]  

  • 17. Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis.
    Lebovics E; Salama M; Elhosseiny A; Rosenthal WS
    Gastroenterology; 1992 Jun; 102(6):2143-7. PubMed ID: 1587436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment for primary sclerosing cholangitis: risk versus benefit.
    Angulo P; Lindor KD
    Hepatology; 2000 Oct; 32(4 Pt 1):871-2. PubMed ID: 11003638
    [No Abstract]   [Full Text] [Related]  

  • 19. Promises, promises: ursodeoxycholic acid for primary sclerosing cholangitis.
    Gross JB
    Gastroenterology; 1993 Mar; 104(3):941-3. PubMed ID: 8440449
    [No Abstract]   [Full Text] [Related]  

  • 20. High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.
    Cullen SN; Rust C; Fleming K; Edwards C; Beuers U; Chapman RW
    J Hepatol; 2008 May; 48(5):792-800. PubMed ID: 18314215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.